B. Riley Wealth Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-286
| Closed | -$2.32K | – | 1673 |
|
|
2023
Q1 | $2.32K | Hold |
286
| – | – | ﹤0.01% | 1510 |
|
|
2022
Q4 | $3.39K | Sell |
286
-21
| -7% | -$249 | ﹤0.01% | 1485 |
|
|
2022
Q3 | $5K | Sell |
307
-53
| -15% | -$863 | ﹤0.01% | 1442 |
|
|
2022
Q2 | $13K | Hold |
360
| – | – | ﹤0.01% | 1215 |
|
|
2022
Q1 | $15K | Hold |
360
| – | – | ﹤0.01% | 1368 |
|
|
2021
Q4 | $16K | Hold |
360
| – | – | ﹤0.01% | 1400 |
|
|
2021
Q3 | $25K | Hold |
360
| – | – | ﹤0.01% | 1389 |
|
|
2021
Q2 | $28K | Buy |
360
+10
| +3% | +$778 | ﹤0.01% | 1359 |
|
|
2021
Q1 | $24K | Sell |
350
-186
| -35% | -$12.8K | ﹤0.01% | 1338 |
|
|
2020
Q4 | $19K | Sell |
536
-21
| -4% | -$744 | ﹤0.01% | 1022 |
|
|
2020
Q3 | $31K | Buy |
557
+21
| +4% | +$1.17K | ﹤0.01% | 931 |
|
|
2020
Q2 | $21K | Hold |
536
| – | – | ﹤0.01% | 856 |
|
|
2020
Q1 | $14K | Hold |
536
| – | – | ﹤0.01% | 782 |
|
|
2019
Q4 | $27K | Hold |
536
| – | – | ﹤0.01% | 826 |
|
|
2019
Q3 | $27K | Buy |
536
+123
| +30% | +$6.2K | ﹤0.01% | 799 |
|
|
2019
Q2 | $38K | Sell |
413
-14
| -3% | -$1.29K | ﹤0.01% | 780 |
|
|
2019
Q1 | $64K | Buy |
427
+95
| +29% | +$14.2K | 0.01% | 716 |
|
|
2018
Q4 | $53K | Hold |
332
| – | – | 0.01% | 644 |
|
|
2018
Q3 | $82K | Buy |
332
+27
| +9% | +$6.67K | 0.01% | 694 |
|
|
2018
Q2 | $69K | Sell |
305
-23
| -7% | -$5.2K | 0.01% | 654 |
|
|
2018
Q1 | $81K | Buy |
328
+7
| +2% | +$1.73K | 0.01% | 635 |
|
|
2017
Q4 | $99K | Buy |
+321
| New | +$99K | 0.01% | 614 |
|
|
2017
Q1 | – | Sell |
-236
| Closed | -$52K | – | 567 |
|
|
2016
Q4 | $52K | Hold |
236
| – | – | 0.01% | 517 |
|
|
2016
Q3 | $57K | Buy |
236
+7
| +3% | +$1.69K | 0.01% | 593 |
|
|
2016
Q2 | $45K | Buy |
+229
| New | +$45K | 0.01% | 593 |
|